Table III.

Relationship between ScaI ANP gene variants and the incidence of “new-onset” AF in 192 patients (after excluding patients with a history of paroxysmal AF before the operation). The analysis was made using a logistic regression model

OR for “new-onset” atrial fibrillation A1A2 vs. A2A2 and A1A1	OR = 0.65 (0.12–3.34)	p = 0.6
OR for “new-onset” atrial fibrillation A2A2 vs. non A2A2	OR = 1.35 (0.59–3.07)	p = 0.46
OR for “new-onset” atrial fibrillation A1A1 vs. non A1A1	OR = 1.8 (0.34–9.5)	p = 0.48

AF – atrial fibrillation, ANP – atrial natriuretic peptide.